These findings reinforce the idea that CDNF has the capability to attenuate both thrombotic and inflammatory processes, which leads to reduced infarct area, mitigates BBB disruption, and promotes neurofunctional recovery following ischemic stroke. This evidence concerns the gene CDNF and ischemic stroke.